Drugs Information: Muromonab
Basic Information
|
||
| ID | DDInter1250 | |
| Drug Type | biotech | |
| Molecular Formula | C6460H9946N1720O2043S56 | |
| Molecular Weight | - | |
| Description | Murine monoclonal antibody specific to CD3 T-cell lymphocyte antigens. More specifically it is a purified murine (mouse) monoclonal antibody, directed against the CD3 (T3) receptor on the surface of human T-cells (T-lymphocytes) cultured using the murine ascites method. Muromonab is 93% monomeric immune globulin G type 2a (IgG2a). | |
| ATC Classification | L04AA02 | |
| IUPAC Name | None | |
| InChI | None | |
| InChI Key | None | |
| Canonical SMILES | None | |
| Useful Links | DrugBank | |
Interactions with Muromonab
| Severity level | ID | Name | Mechanism | Detail |
|---|